# The Medicines for Human Use (Clinical Trials) and Blood Safety and Quality (Amendment) Regulations 2008, Regulation 9: Amendment of regulation 12B of the Blood Regulations


In regulation 12B of the Blood Regulations (requirement to report serious adverse reactions and events), in paragraph (5), for “(3)(b)” substitute “(4)(b)”.

---
Source: https://www.legislation.gov.uk/uksi/2008/941/regulation/9 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-and-blood-safety-and-quality-amendment-regulations-2008/regulation-9
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

